127 related articles for article (PubMed ID: 1084821)
1. The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
Minton JP; Rossio JL; Dixon B; Dodd MC
Clin Exp Immunol; 1976 Jun; 24(3):441-7. PubMed ID: 1084821
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
Webster DJ; Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
[TBL] [Abstract][Full Text] [Related]
3. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 Jan; 35(1):36-44. PubMed ID: 428146
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms in the anti-tumour activity of C. parvum.
Cullen RT
Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
Halpern B; Gauthier-Rahman S; Besluau D
C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
[TBL] [Abstract][Full Text] [Related]
6. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
7. Mitogenicity of Corynebacterium parvum for mouse lymphocytes.
Zola H
Clin Exp Immunol; 1975 Dec; 22(3):514-21. PubMed ID: 817854
[TBL] [Abstract][Full Text] [Related]
8. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation.
Fisher RA
Dev Biol Stand; 1977 Apr 13-15; 38():461-6. PubMed ID: 608539
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies with Corynebacterium parvum.
Mitcheson HD; Castro JE
Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 May; 36(2):227-36. PubMed ID: 314367
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
Gauthier-Rahman S
Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
[TBL] [Abstract][Full Text] [Related]
13. The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice.
Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():195-200. PubMed ID: 415919
[TBL] [Abstract][Full Text] [Related]
14. Toxic and immunologic side effects of daily C. parvum-infusion in treatment-resistant cancer patients.
Mayr AC; Westerhausen M; Senn HJ
Dev Biol Stand; 1977 Apr 13-15; 38():523-7. PubMed ID: 608546
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 Jun; 36(3):456-64. PubMed ID: 487647
[TBL] [Abstract][Full Text] [Related]
16. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
17. Non-specific inhibitory processes of immunological and mitogenic cellular responses.
Liacopoulos M; Lambert F; Liacopoulos P
Immunology; 1980 Sep; 41(1):143-52. PubMed ID: 6448806
[TBL] [Abstract][Full Text] [Related]
18. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
Thatcher N; Crowther D
Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
[TBL] [Abstract][Full Text] [Related]
19. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
Lichtenstein AK; Berek J; Kahle J; Zighelboim J
Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
[TBL] [Abstract][Full Text] [Related]
20. [Hematological observations in patients following immunostimulation through intrapleural application of Corynebacterium parvum].
Karrer K; Denck H; Pridun N
Acta Med Austriaca; 1979; 6(5):209-12. PubMed ID: 233458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
